Results 121 to 130 of about 33,889 (327)

Potential of hyperbaric oxygen in urological diseases [PDF]

, 2019
Tomoaki Tanaka, Akinori Minami, Junji Uchida, Tatsuya Nakatani   +3 more
openalex   +1 more source

Two-sample Mendelian randomization study reveals no causal relationship between inflammatory bowel disease and urological cancers

, 2023
Haoyang Zhang, Can Hu, Zhiyu Zhang, Peng Li, Gang Shen, Jiale Sun   +5 more
openalex   +1 more source

A clinical pathway for the management of Peyronie’s disease: integrating clinical guidelines from the International Society of Sexual Medicine, American Urological Association and European Urological Association [PDF]

, 2020
Eric Chung, Michael Gillman, John Tuckey, Shane La Bianca, Chris Love   +4 more
openalex   +1 more source

What Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Artificial intelligence (AI) is poised to improve the diagnosis and management of lower urinary tract dysfunction (LUTD). Its effective deployment requires prioritization, regulatory oversight, rigorous validation, and clinician and patient engagement.
Glenn T. Werneburg, Michel Wyndaele, John E. Speich, Enrico Finazzi Agro, Mo Belal, Sachin Malde, George Bou Kheir, Emre Huri, Arjun K. Nambiar, Giovanni Mosiello, Riccardo Lombardo, Phil Toozs‐Hobson, Christopher R. Chapple, Alan J. Wein, Paul Abrams, Kevin Rademakers   +15 more
wiley   +1 more source

The role of ubiquitination and deubiquitination in urological tumours

Frontiers in Pharmacology
The ubiquitin (Ub) system has been demonstrated to play a crucial role in various cellular processes, including immune responses, cell development, and programmed cell death. Ubiquitination, a form of post-translational modification, occurs in eukaryotic
Lifeng Gan, Lifeng Gan, Lifeng Gan, Peiyue Luo, Peiyue Luo, Peiyue Luo, Junrong Zou, Junrong Zou, Wei Li, Wei Li, Wei Li, Qi Chen, Qi Chen, Qi Chen, Le Cheng, Le Cheng, Le Cheng, Fangtao Zhang, Fangtao Zhang, Fangtao Zhang, Haidong Zhong, Haidong Zhong, Haidong Zhong, Liying Zheng, Biao Qian, Biao Qian   +25 more
doaj   +1 more source

Synthetic DNA immunotherapy in biochemically relapsed prostate cancer [PDF]

, 2018
Background: INO-5150 (PSA and PSMA) +/- INO-9012 (IL-12), a synthetic DNA immunotherapy, was assessed for safety, immunogenicity and efficacy in biochemically recurrent prostate cancer patients (pts).
Appleman, L. J., Bagarazzi, M. L., Bhatt, K., Cheng, H., Csiki, I., Garcia, J., Heath, E. I., Kelly, W., Kraynyak, K., Lee, J., Liu, L., McMullan, T., Morrow, M., Nordquist, L. T., Rosencranz, S., Sacchetta, B., Shore, N., Tagawa, S. T., Tutrone, R., Whang, Y.   +19 more
core   +1 more source

What Role Does the Central Nervous System Play in Refractory LUTS, and What Are the Therapeutic Implications? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims While many patients with lower urinary tract symptoms (LUTS) improve by treating peripheral causes, a substantial proportion continue to experience symptoms despite apparently successful interventions. Central nervous system (CNS) mechanisms could potentially contribute to persisting symptoms after the initial peripheral cause has been ...
Mathijs M. de Rijk, Michel Wyndaele, Ana Charrua, Christopher Fry, Paul Abrams, Gommert A. van Koeveringe, Anthony J. Kanai, Marcus J. Drake   +7 more
wiley   +1 more source

Corrigendum: Correction of the Acknowledgments. Prevalence and management status of urologic disease in geriatric hospitals in South Korea: A population-based analysis [PDF]

, 2018
Jungyo Suh, Khae Hawn Kim, Sang‐Heon Lee, Hyung Suk Kim, Young Ju Lee, Sang Rim Lee, Chang Wook Jeong   +6 more
openalex   +1 more source

American Foundation for Urologic Disease, Inc. (AFUD) [PDF]

, 2021

openalex   +1 more source

Save the Bladder: Continent Urinary Diversion as Best Practice for Patients With Refractory Neurogenic Lower Urinary Tract Dysfunction

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Refractory neurogenic lower urinary tract dysfunction presents an obstinate clinical problem. For patients who fail nonsurgical measures, we advocate for bladder‐sparing, continent urinary diversion as the optimal approach to management.
Brian W. Chao, Sean P. Elliott
wiley   +1 more source